life science investing MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
life science investing MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
FPX Nickel Receives Multi-Year Area-Based Permit and Commences 2025 Drilling Activities at Baptiste Nickel Project
